CAPSULES BISMUTH RESORCINOL COMPOUND NOT ADMITTED TO N. N. R.

Report of the Council on Pharmacy and Chemistry

In response to inquiries received, the Council took up the consideration of Capsules Bismuth Resorcinol Compound (The Gross Drug Company, Inc., New York City). The label, sent by the Gross Drug Company, bore the following:

Capsules

Bismuth Resorcinol Compound

Bismuth Subgallate

2 grs.

Resorcinol

1 gr.

Beta Naphthol

 1⁄2 gr.

Creosote (Beechwood)

1 m.
This combination is of acknowledged value in re­duc­ing the in­tes­tinalpu­tre­fac­tion and fer­men­ta­tion, al­lay­ing the pain and dis­com­fortof flat­ulent con­di­tions in the intestinal tract.
Dose.—One or two capsules before or after meals repeated in twohours if necessary.
The Gross Drug Company, Inc.
20 Laight Street, New York

The Council held this preparation inadmissible to New and Non­official Remedies or the Appendix, because (1) the claim “acknowledged value in reducing the intestinal putrefaction and fermentation, allaying the pain and discomfort of flatulent conditions in the intestinal tract” is an unwarranted, exaggerated and misleading claim of therapeutic value (Rule 6); because (2) the name does not indicate the identity of the bismuth salt contained in the capsules, nor declare the presence of betanaphthol and creosote (Rule 8); and because (3) the combination of bismuth subgallate, resorcinol, betanaphthol and creosote in fixed proportions is irrational (Rule 10).—(From Reports of Council on Pharmacy and Chemistry, 1917, p. 139.)